LipoTrue leverages artificial intelligence to engineer Cellaigie, a peptide designed to modulate mTOR activity and promote autophagy for sustained skin vitality. By analyzing molecular datasets, AI identifies structures that enhance cellular cleanup, protect against ageing drivers, and improve firmness, elasticity and radiance. This bio-intelligent approach shifts skincare from surface treatments to targeted longevity strategies.
Key points
- AI-driven peptide design identifies Cellaigie to target mTOR modulation and autophagy enhancement.
- Cellaigie mimics fasting and HIIT effects by shifting cells into maintenance state for repair.
- Active ingredient supports protein quality control, reduces senescence markers and optimizes cellular energy management.
- Topical testing shows improvements in skin luminosity, reduction of fine lines and increased elasticity.
- Integration of longevity biology frameworks enables evidence-based, high-performance skincare actives.
Why it matters: This convergence of AI and longevity science heralds a paradigm shift in skincare R&D by moving beyond cosmetic masking to mechanistic, cellular-level interventions. By automating peptide discovery and targeting core aging pathways, brands can deliver evidence-based efficacy, faster development cycles and personalized formulations that address the root causes of skin aging.
Q&A
- What is mTOR?
- How does AI design peptides?
- What is autophagy and why is it important in skincare?
- How does Cellaigie mimic fasting and HIIT benefits?